Flagship Biosciences delivers comprehensive tissue profiling using our Artificial Intelligence (AI) enabled cTA® pathology platform.
Flagship Biosciences has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.
Flagship Biosciences is headquartered in Westminster, United States.
Flagship Biosciences delivers comprehensive tissue profiling using our Artificial Intelligence (AI) enabled cTA® pathology platform.
Flagship Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Flagship Biosciences — Funding & Investors." VCBacked, April 16, 2024, https://www.vcbacked.co/company/flagship-biosciences. Accessed August 14, 2026.
VCBacked. (2024). Flagship Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/flagship-biosciences
{{cite web |title=Flagship Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/flagship-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated